Funding for this research was provided by:
Varian Medical Systems
Received: 28 October 2020
Accepted: 6 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: This study was approved by the ethics committees at all participating sites (BASEC-Nr. 2016-01807). A informed consent of all participants was obtained.
: Not applicable.
: SA is supported by the German Cancer Consortium (DKTK), M Geier received a speaker fee from Roche and a speaker fee from Bristol-Myers-Squibb. SS is supported by a National Health and Medical Research Council (NHMRC) fellowship, and Cancer Council Victoria (CCV) Colebatch Fellowship. MS received a speaker fee from Merck Serono, AstraZeneca and Pierre Fabre. SK received a speaker fee from AstraZeneca.